187 related articles for article (PubMed ID: 18269457)
1. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
Matsumoto K; Fujiwara Y; Nagai R; Yoshida M; Ueda S
Int J Urol; 2008 Feb; 15(2):166-70. PubMed ID: 18269457
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
3. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
[TBL] [Abstract][Full Text] [Related]
4. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
5. Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues.
Sakashita N; Miyazaki A; Takeya M; Horiuchi S; Chang CC; Chang TY; Takahashi K
Am J Pathol; 2000 Jan; 156(1):227-36. PubMed ID: 10623671
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.
Liang K; Vaziri ND
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884
[TBL] [Abstract][Full Text] [Related]
7. Acyl-coenzyme A:cholesterol acyltransferase-2 (ACAT-2) is responsible for elevated intestinal ACAT activity in diabetic rats.
Hori M; Satoh M; Furukawa K; Sakamoto Y; Hakamata H; Komohara Y; Takeya M; Sasaki Y; Miyazaki A; Horiuchi S
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1689-95. PubMed ID: 15242859
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.
Hashimoto Y; Kondo Y; Kimura G; Matsuzawa I; Sato S; Ishizaki M; Imura N; Akimoto M; Hara S
Histopathology; 2004 Apr; 44(4):353-9. PubMed ID: 15049901
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA
J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
[TBL] [Abstract][Full Text] [Related]
11. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
Campbell L; Nuttall R; Griffiths D; Gumbleton M
Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
[TBL] [Abstract][Full Text] [Related]
12. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue.
Simić T; Mimić-Oka J; Ille K; Dragicević D; Savić-Radojević A
World J Urol; 2003 May; 20(6):385-91. PubMed ID: 12811499
[TBL] [Abstract][Full Text] [Related]
14. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of erythropoietin expression in human renal cell carcinoma.
Michael A; Politi E; Havranek E; Corbishley C; Karapanagiotou L; Anderson C; Relph K; Syrigos KN; Pandha H
BJU Int; 2007 Aug; 100(2):291-4. PubMed ID: 17617137
[TBL] [Abstract][Full Text] [Related]
16. Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma.
Mungan MU; Gurel D; Canda AE; Tuna B; Yorukoglu K; Kirkali Z
Eur Urol; 2006 Jul; 50(1):92-7; discussion 97. PubMed ID: 16426736
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
18. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation.
Grignon DJ; Abdel-Malak M; Mertens WC; Sakr WA; Shepherd RR
Mod Pathol; 1994 Feb; 7(2):186-9. PubMed ID: 8008741
[TBL] [Abstract][Full Text] [Related]
20. Panel of candidate biomarkers for renal cell carcinoma.
Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
